Starpharma Holdings Limited - Latest News [Page 1]
Starpharma Commences Bacterial Vaginosis Prevention Study
Monday, 15 August 2011, 3:24 pm | Starpharma Holdings Limited
Starpharma Commences Bacterial Vaginosis Prevention Study of VivaGel® Melbourne Australia; 15 August 2011 : Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the commencement of its Phase 2 study of VivaGel® for the prevention of ... More >>
VivaGel Presented at Herpes Management Forum
Thursday, 11 October 2007, 4:18 pm | Starpharma Holdings Limited
It is estimated that by 2025, 40-50% of women in the U.S. will be infected with HSV-2. Genital herpes is a recurrent, lifelong viral infection, and is the most common cause of genital ulcer disease. More >>